Cost-effectiveness of low-dose colchicine in patients with chronic coronary disease in the netherlands.

Aernoud T L FioletWillem KeustersJohan BlokzijlS Mark NidorfJohn E EikelboomCharley A BudgeonJan G P TijssenTjeerd RömerIris WestendorpJan Hein CornelPeter L ThompsonGeert W J FrederixArend MosterdG Ardine de Wit

Published in: European heart journal. Quality of care & clinical outcomes (2024)

Adding low-dose colchicine to standard of care in patients with chronic coronary disease is cost-effective according to commonly accepted thresholds in Europe and Australia and compares favourably in cost-effectiveness to other drugs used in chronic coronary disease.

Keyphrases

low dose
coronary artery disease
coronary artery
high dose
healthcare
palliative care
aortic stenosis
pain management
drug induced
transcatheter aortic valve replacement
ejection fraction